Objectives: The aim of this study was to explore the potential correlation between the GA/HbA1c ratio and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), as the GA/HbA1c ratio serves as a marker for ...Objectives: The aim of this study was to explore the potential correlation between the GA/HbA1c ratio and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), as the GA/HbA1c ratio serves as a marker for glycemic variability. Methods: A total of 2565 T2D patients were included in this study and grouped into five categories based on the diagnostic criteria for DR. We examined the impact of the GA/HbA1c ratio on the progression of diabetes. Results: The non-DR group exhibited lower GA/HbA1c levels compared to the DR group. Additionally, as the severity of DR increased among the five groups, there was a corresponding increase in the GA/HbA1c ratio. Logistic regression analysis demonstrated that the GA/HbA1c ratio independently elevated the risk of DR occurrence. Conclusions: The GA/HbA1c ratio can independently predict the occurrence and progression of diabetic retinopathy.展开更多
目的探讨GA/HbA1c比值测定在早期糖尿病肾病患者诊断中的价值。方法随机抽取2014年10月至2017年3月在该院老年科、内分泌科及肾内科住院确诊的68例2型糖尿病(T2DM)患者,按患者24小时尿蛋白定量(24 h pro)水平分为正常蛋白尿(NAU)组及糖...目的探讨GA/HbA1c比值测定在早期糖尿病肾病患者诊断中的价值。方法随机抽取2014年10月至2017年3月在该院老年科、内分泌科及肾内科住院确诊的68例2型糖尿病(T2DM)患者,按患者24小时尿蛋白定量(24 h pro)水平分为正常蛋白尿(NAU)组及糖尿病肾病(DN)组,DN组患者再分为微量蛋白尿(MAU)亚组和临床蛋白尿(CAU)亚组;另选42例健康体检者为对照组(NC组)。所有受检者均检测血清尿素氮(BUN)、肌酐(Cr)、糖化血清蛋白(GA)、糖化血红蛋白(HbA1c)及24 h pro等各项生化指标,计算GA/HbA1c比值。结果与NC组相比,NUA组、DN组GA、HbA1c、24 h pro水平及GA/HbA1c比值均显著升高(P<0.05)。在T2DM患者中,GA/HbA1c比值与24 h pro呈正相关,但在CAU组中的相关性偏低。结论 GA/HbA1c比值有望作为早期检测糖尿病肾病的潜在临床指标,但对晚期肾损害不敏感。展开更多
文摘Objectives: The aim of this study was to explore the potential correlation between the GA/HbA1c ratio and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), as the GA/HbA1c ratio serves as a marker for glycemic variability. Methods: A total of 2565 T2D patients were included in this study and grouped into five categories based on the diagnostic criteria for DR. We examined the impact of the GA/HbA1c ratio on the progression of diabetes. Results: The non-DR group exhibited lower GA/HbA1c levels compared to the DR group. Additionally, as the severity of DR increased among the five groups, there was a corresponding increase in the GA/HbA1c ratio. Logistic regression analysis demonstrated that the GA/HbA1c ratio independently elevated the risk of DR occurrence. Conclusions: The GA/HbA1c ratio can independently predict the occurrence and progression of diabetic retinopathy.
文摘目的探讨GA/HbA1c比值测定在早期糖尿病肾病患者诊断中的价值。方法随机抽取2014年10月至2017年3月在该院老年科、内分泌科及肾内科住院确诊的68例2型糖尿病(T2DM)患者,按患者24小时尿蛋白定量(24 h pro)水平分为正常蛋白尿(NAU)组及糖尿病肾病(DN)组,DN组患者再分为微量蛋白尿(MAU)亚组和临床蛋白尿(CAU)亚组;另选42例健康体检者为对照组(NC组)。所有受检者均检测血清尿素氮(BUN)、肌酐(Cr)、糖化血清蛋白(GA)、糖化血红蛋白(HbA1c)及24 h pro等各项生化指标,计算GA/HbA1c比值。结果与NC组相比,NUA组、DN组GA、HbA1c、24 h pro水平及GA/HbA1c比值均显著升高(P<0.05)。在T2DM患者中,GA/HbA1c比值与24 h pro呈正相关,但在CAU组中的相关性偏低。结论 GA/HbA1c比值有望作为早期检测糖尿病肾病的潜在临床指标,但对晚期肾损害不敏感。